Head-to-head · Value Score
CoreAge Rx vs Breeze Meds
Two GLP-1 deals, scored on the same six factors. CoreAge Rx lands a Value Score of 93, Breeze Meds a 78. Here's who gives you the honest lower price — and where each one bites back.
CoreAge Rx
#1 · Grade A+ · Best Value
Est. first month
$99/mo
Save ~89% vs brand-nameBreeze Meds
#56 · Grade B- · Fair Price
Est. first month
From $199/mo injectable (lowest dose)
Save ~85% vs brand-nameThe verdict
CoreAge Rx takes it on Value Score, 93 to 78 — an est. $99/mo first month, with no teaser step-up baked in. Breeze Meds isn't out of it: Shoppers who want a no-risk start and will ask what their actual dose costs before committing.
CoreAge Rx is also our overall #1 pick across the whole deals ranking — a flat, all-in price on both molecules in all 50 states. That's why it wins here on the score, not just this matchup.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | CoreAge Rx | Breeze Meds |
|---|---|---|
| Value Score | 93 (A+) | 78 (B-) |
| Est. first month | $99/mo | From $199/mo injectable (lowest dose) |
| Save vs brand-name | ~89% | ~85% |
| Semaglutide | $99/mo | From $199/mo injectable · from $299/mo oral |
| Tirzepatide | $149/mo | From $299/mo first month, $399/mo thereafter · from $399/mo oral |
| Both molecules | Yes | Yes |
| Pricing | Flat — no step-up | Watch |
| Coverage | All 50 states | All 50 states |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
CoreAge Rx
The honest lowest price: both molecules at one flat, all-in monthly rate that never steps up after month one.
Why it's a deal
- Flat, all-in monthly price with no intro-rate step-ups after month one
- Both compounded semaglutide and tirzepatide on one account
- Available in all 50 states
- Straightforward, low-friction cancellation — no lock-in
The fine print
- Not the rock-bottom sticker — a couple of teaser tiers advertise lower month-one rates
- No FDA-approved brand-name option (compounded only)
- Does not yet publicly name its 503A/B pharmacy partner
Breeze Meds
Nationwide and charges nothing until you are approved, but its quoted prices are floors rather than what a working dose costs.
Why it's a deal
- Nothing charged until a provider approves you, and the consult is free if you go ahead
- One inclusive price covering consult, medication, supplies, shipping and support
- LegitScript certified, all 50 states, cancel or change plan at any time
The fine print
- Every figure quoted is for the LOWEST dose — the funnel says higher doses may cost more
- The $299 tirzepatide is a first-month rate; month-to-month is $399
- No molecule is named behind the public "from $199" — pricing only appears inside the intake
- An $80 consultation fee applies if you are approved and then decline
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
Neither one the right fit? Every program that outscores CoreAge Rx is ranked on the CoreAge Rx alternatives ranking, and the same list for the other side is on alternatives to Breeze Meds.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.